Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28404010)

Published in Lancet Gastroenterol Hepatol on November 11, 2016

Authors

Caryn S Ross-Innes1, Hamza Chettouh1, Achilleas Achilleos1, Nuria Galeano-Dalmau1, Irene Debiram-Beecham1, Shona MacRae1, Petros Fessas1, Elaine Walker1, Sibu Varghese1, Theodore Evan1, Pierre S Lao-Sirieix1, Maria O'Donovan2, Shalini Malhotra2, Marco Novelli3, Babett Disep4, Phillip V Kaye5, Laurence B Lovat3, Rehan Haidry3, Michael Griffin4, Krish Ragunath5, Pradeep Bhandari6, Adam Haycock7, Danielle Morris8, Stephen Attwood9, Anjan Dhar10, Colin Rees11, Matt D Rutter12, Richard Ostler13, Benoit Aigret13, Peter D Sasieni13, Rebecca C Fitzgerald14, BEST2 study group

Author Affiliations

1: MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.
2: Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK.
3: University College London Hospital, London, UK.
4: Royal Victoria Infirmary, Newcastle upon Tyne, UK.
5: NIHR Nottingham Digestive Disease Biomedical Research Unit, Queens Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, UK.
6: Queen Alexandra Hospital, Portsmouth, UK.
7: Saint Mark's Hospital, London, UK.
8: East and North Hertfordshire NHS Trust, QEII and Lister Hospitals, Stevenage, UK.
9: Northern Region Endoscopy Group, UK; North Tyneside General Hospital, North Shields, UK.
10: Northern Region Endoscopy Group, UK; County Durham and Darlington NHS Foundation Trust, Durham, UK.
11: Northern Region Endoscopy Group, UK; South Tyneside NHS Foundation Trust, Tyne and Wear, UK.
12: Northern Region Endoscopy Group, UK; North Tees and Hartlepool NHS Foundation Trust, Hartlepool, UK.
13: UK Cancer Prevention Trials Unit, London, UK.
14: MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK. Electronic address: rcf29@MRC-CU.cam.ac.uk.